Drug intelligence / Profile preview

SelPine-TZ

Development stage
Unknown
Lead developer
Unifaith Biotech
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

SelPine-TZ is a combination antibiotic injection marketed by Unifaith Biotech, primarily used for treating moderate to severe bacterial infections, including those caused by resistant organisms. It is a fixed-dose combination containing cefepime, a fourth-generation cephalosporin, and tazobactam, a beta-lactamase inhibitor. Cefepime exerts its bactericidal activity by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs). Tazobactam is added to expand the spectrum of activity against beta-lactamase-producing bacteria by irreversibly inhibiting various beta-lactamase enzymes that would otherwise degrade cefepime. The product is typically available in a 1.125g strength (1000mg cefepime and 125mg tazobactam) for parenteral administration.

Brand names
SelPine-TZSefpine TZ
Other names
Cefepime + Tazobactam
02

Targets

β-lactamasePBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on SelPine-TZ.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SelPine-TZ.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call